117 related articles for article (PubMed ID: 19781605)
21. Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications.
Lince F; Marchisio DL; Barresi AA
J Colloid Interface Sci; 2008 Jun; 322(2):505-15. PubMed ID: 18402975
[TBL] [Abstract][Full Text] [Related]
22. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
23. Formulation of BCNU-loaded microspheres: influence of drug stability and solubility on the design of the microencapsulation procedure.
Torres AI; Boisdron-Celle M; Benoit JP
J Microencapsul; 1996; 13(1):41-51. PubMed ID: 8903784
[TBL] [Abstract][Full Text] [Related]
24. Novel amphiphilic poly(epsilon-caprolactone)-g-poly(L-lysine) degradable copolymers.
Nottelet B; El Ghzaoui A; Coudane J; Vert M
Biomacromolecules; 2007 Aug; 8(8):2594-601. PubMed ID: 17625909
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterization and thermal properties of chitin-g-poly(epsilon-caprolactone) copolymers by using chitin gel.
Jayakumar R; Tamura H
Int J Biol Macromol; 2008 Jul; 43(1):32-6. PubMed ID: 17950453
[TBL] [Abstract][Full Text] [Related]
26. Integrity characterization of myoglobin released from poly(ε-caprolactone) microspheres using two analytical methods: UV/Vis spectrometry and conductometric bi-enzymatic biosensor.
Hnaien M; Ruffin E; Bordes C; Marcillat O; Lagarde F; Jaffrezic-Renault N; Briançon S
Eur J Pharm Biopharm; 2011 Jun; 78(2):298-305. PubMed ID: 21284956
[TBL] [Abstract][Full Text] [Related]
27. Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres.
Li X; Zhang Y; Yan R; Jia W; Yuan M; Deng X; Huang Z
J Control Release; 2000 Jul; 68(1):41-52. PubMed ID: 10884578
[TBL] [Abstract][Full Text] [Related]
28. Characterization of polymeric poly(epsilon-caprolactone) injectable implant delivery system for the controlled delivery of contraceptive steroids.
Dhanaraju MD; Gopinath D; Ahmed MR; Jayakumar R; Vamsadhara C
J Biomed Mater Res A; 2006 Jan; 76(1):63-72. PubMed ID: 16108044
[TBL] [Abstract][Full Text] [Related]
29. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology.
Freitas S; Merkle HP; Gander B
J Control Release; 2005 Feb; 102(2):313-32. PubMed ID: 15653154
[TBL] [Abstract][Full Text] [Related]
30. Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique.
Ugwoke MI; Kinget R
J Microencapsul; 1998; 15(3):273-81. PubMed ID: 9608392
[TBL] [Abstract][Full Text] [Related]
31. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
[TBL] [Abstract][Full Text] [Related]
32. Another paradigm in solvent extraction-based microencapsulation technologies.
Im HY; Kim J; Sah H
Biomacromolecules; 2010 Mar; 11(3):776-86. PubMed ID: 20131759
[TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of self-assembled nanoparticles formed by poly(ethylene oxide)-block-poly(epsilon-caprolactone) copolymers with long poly(epsilon-caprolactone) blocks in aqueous solutions.
Sachl R; Uchman M; Matĕjícek P; Procházka K; Stĕpánek M; Spírková M
Langmuir; 2007 Mar; 23(6):3395-400. PubMed ID: 17269809
[TBL] [Abstract][Full Text] [Related]
34. Microencapsulation of rosmarinic acid using polycaprolactone and various surfactants.
Kim HJ; Kim TH; Kang KC; Pyo HB; Jeong HH
Int J Cosmet Sci; 2010 Jun; 32(3):185-91. PubMed ID: 20557576
[TBL] [Abstract][Full Text] [Related]
35. Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties.
Gangrade N; Price JC
J Microencapsul; 1991; 8(2):185-202. PubMed ID: 1765899
[TBL] [Abstract][Full Text] [Related]
36. Polymers for biodegradable medical devices. X. Microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending.
Embleton JK; Tighe BJ
J Microencapsul; 1993; 10(3):341-52. PubMed ID: 8377092
[TBL] [Abstract][Full Text] [Related]
37. Microencapsulation by solvent evaporation: state of the art for process engineering approaches.
Li M; Rouaud O; Poncelet D
Int J Pharm; 2008 Nov; 363(1-2):26-39. PubMed ID: 18706988
[TBL] [Abstract][Full Text] [Related]
38. Microencapsulation techniques, factors influencing encapsulation efficiency.
Jyothi NV; Prasanna PM; Sakarkar SN; Prabha KS; Ramaiah PS; Srawan GY
J Microencapsul; 2010 May; 27(3):187-97. PubMed ID: 20406093
[TBL] [Abstract][Full Text] [Related]
39. All-trans-retinoic acid release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymer.
Jeong YI; Kang MK; Sun HS; Kang SS; Kim HW; Moon KS; Lee KJ; Kim SH; Jung S
Int J Pharm; 2004 Apr; 273(1-2):95-107. PubMed ID: 15010134
[TBL] [Abstract][Full Text] [Related]
40. Surface properties and biocompatibility of solvent-cast poly[-caprolactone] films.
Tang ZG; Black RA; Curran JM; Hunt JA; Rhodes NP; Williams DF
Biomaterials; 2004 Aug; 25(19):4741-8. PubMed ID: 15120520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
